Y Intercept Hong Kong Ltd grew its holdings in Celsius Holdings Inc. (NASDAQ:CELH – Free Report) by 101.8% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 365,023 shares of the company’s stock after purchasing an additional 184,173 shares during the period. Celsius makes up about 0.4% of Y Intercept Hong Kong Ltd’s holdings, making the stock its 20th biggest position. Y Intercept Hong Kong Ltd owned about 0.14% of Celsius worth $16,933,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors also recently modified their holdings of the business. Alliancebernstein L.P. grew its stake in Celsius by 26.3% during the first quarter. Alliancebernstein L.P. now owns 18,045,178 shares of the company’s stock valued at $642,769,000 after acquiring an additional 3,753,055 shares in the last quarter. AQR Capital Management LLC purchased a new position in Celsius in the 1st quarter worth approximately $39,412,000. Lord Abbett & CO. LLC purchased a new position in Celsius in the 1st quarter worth approximately $36,511,000. Assenagon Asset Management S.A. grew its stake in Celsius by 9,579.6% in the 2nd quarter. Assenagon Asset Management S.A. now owns 828,860 shares of the company’s stock worth $38,451,000 after buying an additional 820,297 shares in the last quarter. Finally, Broad Bay Capital Management LP purchased a new position in Celsius in the 1st quarter worth approximately $24,374,000. Institutional investors own 60.95% of the company’s stock.
Celsius Stock Performance
Shares of NASDAQ CELH opened at $63.35 on Monday. The firm’s 50-day moving average price is $59.26 and its 200-day moving average price is $47.98. The company has a quick ratio of 1.76, a current ratio of 2.11 and a debt-to-equity ratio of 0.68. The company has a market cap of $16.34 billion, a PE ratio of 171.22, a PEG ratio of 1.29 and a beta of 1.38. Celsius Holdings Inc. has a 52-week low of $21.10 and a 52-week high of $66.74.
Analyst Upgrades and Downgrades
CELH has been the subject of a number of research reports. The Goldman Sachs Group initiated coverage on shares of Celsius in a research note on Thursday, September 11th. They issued a “buy” rating and a $72.00 price target for the company. Citigroup reissued a “buy” rating on shares of Celsius in a research note on Sunday, August 31st. Maxim Group boosted their price target on shares of Celsius from $50.00 to $65.00 and gave the stock a “buy” rating in a research note on Friday, August 8th. Stephens reissued an “overweight” rating on shares of Celsius in a research note on Monday, August 11th. Finally, Weiss Ratings restated a “hold (c-)” rating on shares of Celsius in a report on Tuesday, October 14th. Nineteen investment analysts have rated the stock with a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $64.45.
Read Our Latest Stock Report on CELH
Insider Activity at Celsius
In other Celsius news, CEO John Fieldly sold 143,167 shares of the firm’s stock in a transaction that occurred on Thursday, August 7th. The shares were sold at an average price of $51.18, for a total transaction of $7,327,287.06. Following the sale, the chief executive officer owned 895,410 shares in the company, valued at approximately $45,827,083.80. This trade represents a 13.78% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Jarrod Langhans sold 5,000 shares of the stock in a transaction that occurred on Thursday, October 16th. The shares were sold at an average price of $65.00, for a total transaction of $325,000.00. Following the sale, the chief financial officer directly owned 99,227 shares of the company’s stock, valued at approximately $6,449,755. This trade represents a 4.80% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 405,667 shares of company stock worth $20,665,162 in the last 90 days. Insiders own 2.20% of the company’s stock.
Celsius Profile
Celsius Holdings, Inc develops, processes, markets, distributes, and sells functional energy drinks and liquid supplements in the United States, Australia, New Zealand, Canadian, European, Middle Eastern, Asia-Pacific, and internationally. The company offers CELSIUS, a fitness drink or supplement designed to accelerate metabolism and burn body fat; various flavors and carbonated and non-carbonated functional energy drinks under the CELSIUS Originals and Vibe name, as well as functional energy drink under the CELSIUS Essentials and CELSIUS On-the-Go Powder names; and CELSIUS ready-to drink products.
Featured Stories
- Five stocks we like better than Celsius
- Pros And Cons Of Monthly Dividend Stocks
- PulteGroup Is Down But Not Out—Here’s What Wall Street Missed
- What is a Microcap Stock? Everything You Need to Know
- Cleveland-Cliffs Breaks to New Highs on Earnings, More Upside?
- Stock Dividend Cuts Happen Are You Ready?
- Is Landstar the Next Big Winner in Transportation Stocks?
Want to see what other hedge funds are holding CELH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Celsius Holdings Inc. (NASDAQ:CELH – Free Report).
Receive News & Ratings for Celsius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Celsius and related companies with MarketBeat.com's FREE daily email newsletter.
